Last updated on 4 Sept 2024
Owner Info
Boston Pharmaceuticals, Inc.
55 Cambridge Parkway, Suite 401
Cambridge MA 02142, UNITED STATES OF AMERICA
Serial Number
2447216 filed on 21 Mar 2024
Correspondent
Camille M. Miller Cozen O'Connor
1650 Market Street, Suite 2800,
Philadelphia PA 19103,
UNITED STATES OF AMERICA
2447216
NA
NA
FIGURATIVE
20 Dec 2023
US
Status Date | Action Taken |
---|---|
4th Sept 2024 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
3rd Sept 2024 | International Registration in Australia Protected After Adverse (No amendments) correspondence sent |
3rd Sept 2024 | IP Right Registration Published |
3rd Sept 2024 | Status change to Registered/Protected |
28th Jun 2024 | Application Accepted correspondence sent |
27th Jun 2024 | Application Accepted correspondence sent |
27th Jun 2024 | IP Right has been Examined |
27th Jun 2024 | IP Right Acceptance Published |
27th Jun 2024 | Status change to Accepted |
31st May 2024 | Examination Response Received |